首页> 美国卫生研究院文献>other >Evidence That p-Cresol and IL-6 Are Adsorbed by the HFR Cartridge: Towards a New Strategy to Decrease Systemic Inflammation in Dialyzed Patients?
【2h】

Evidence That p-Cresol and IL-6 Are Adsorbed by the HFR Cartridge: Towards a New Strategy to Decrease Systemic Inflammation in Dialyzed Patients?

机译:HFR药筒吸附对甲酚和IL-6的证据:寻求一种减少透析患者全身性炎症的新策略?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

IntroductionHemodialysis (HD) and hemodiafiltration clear only with a low efficiency the plasma from interleukin-6 and p-cresol, two protein-bound uremic toxins associated with high cardiovascular risk in end stage renal disease. HFR Supra is a double-chamber hemodiafiltration system in which the ultrafiltrate returns to the patient after its regeneration through a resin cartridge that binds hydrophobic and protein-bound solutes. In the present study, we evaluated whether the HFR cartridge can also bind total p-cresol and IL-6 and remove them from the ultrafiltrate.
机译:简介血液透析(HD)和血液透析滤过仅能以较低的效率清除来自白细胞介素6和对甲酚的血浆,这两种蛋白结合的尿毒症毒素与终末期肾脏疾病的高心血管风险有关。 HFR Supra是一种双室血液透析滤过系统,其中超滤液在通过结合疏水性和结合蛋白质的溶质的树脂药筒再生后返回患者。在本研究中,我们评估了HFR药筒是否也可以结合总的对甲酚和IL-6并将其从超滤液中去除。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号